In addition to a broad portfolio of products and vaccines, Boehringer Ingelheim Vetmedica, Inc. provides strong leadership in the animal health industry by providing numerous innovations spanning diagnostics collaboration, disease management tools, and other industry support and education opportunities.
Merial is a global animal health company with our North America headquarters located in Duluth, Georgia. Merial provides veterinarians across the region a comprehensive range of products to enhance the health and well-being of a wide range of animals.
“We believe prevention is a better approach to animal health.”
Merial is now owned by Boehringer Ingelheim and combined with their animal health business, Boehringer Ingelheim Vetmedica, to form Boehringer Ingelheim Animal Health. Boehringer Ingelheim is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally. The focus of the family-owned company, founded in 1885, is on researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine. The company also focuses on environmental protection and sustainability in everything it does.
Boehringer Ingelheim Animal Health global headquarters is located in Ingelheim, Germany, with regional offices in Singapore and Duluth, GA, USA.